[Federal Register: December 19, 2002 (Volume 67, Number 244)] [Notices] [Page 77798] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr19de02-74] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee; Cancellation AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is canceling the meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for December 20, 2002. This meeting was announced in the Federal Register of November 13, 2002 (67 FR 68878). FOR FURTHER INFORMATION CONTACT: Kimberly L. Topper, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX 301-827-6776, or e-mail: topperk@cder.fda.gov, or FDA Advisory Committee Information Line, 1- 800-741-8138 (301-443-0572 in the Washington, DC area), code 12545. Dated: December 16, 2002. Linda Arey Skladany, Associate Commissioner for External Relations. [FR Doc. 02-32157 Filed 12-17-02; 3:05 pm] BILLING CODE 4160-01-S